Skip to content

Clinical trials

Completed Adenocarcinoma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Singapore Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20142
20163
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Ariad Pharmaceuticals1
Celgene1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Imunon1
NantCell, Inc.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma10
Neoplasms5
Carcinoma4
Carcinoma, Non-Small-Cell Lung4
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasms by Site4
Colonic Neoplasms3
Colorectal Neoplasms3
Endocrine Gland Neoplasms3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.